Journal of Cancer Immunology & Therapy

Editorial P.1-2

Current state of immunotherapy: chipping away at the tip of the iceberg.

Author(s): Nisha Mohindra

DOI: 10.35841/cancer-immunology.1.1.1-2

Abstract Full Text PDF

Editorial P.3-3

High-dose chemotherapy in germ cell tumors: an old story still young.

Author(s): Giovanni Rosti

DOI: 10.35841/cancer-immunology.1.1.3

Abstract Full Text PDF

Editorial P.4-5

Impact of immune checkpoint inhibitors in cancer immunotherapy.

Author(s): Kota V Ramana

DOI: 10.35841/cancer-immunology.1.1.4-5

Abstract Full Text PDF

Short Communication P.6-7

MRI-guided stereotactic radiation therapy for prostate cancer: a mini review.

Author(s): Aryavarta M S Kuma

DOI: 10.35841/cancer-immunology.1.1.6-7

Abstract Full Text PDF

Editorial P.8-8

Glycosphingolipids-function and useage.

Author(s): Clifford Lingwoo

DOI: 10.35841/cancer-immunology.1.1.8

Abstract Full Text PDF

Review Paper P.9-16

Recent advances in exosome-based cancer immunotherapy.

Author(s): Yubin Zhou, Qun Zeng, Herbert Schwarz

DOI: 10.35841/cancer-immunology.1.1.9-16

Abstract Full Text

Review Article P.17-23

Advanced and metastatic soft tissue sarcoma, a review of aajcc 8th edition staging and the use of olaratumab.

Author(s): Hari A Deshpande, Ranjan Pathak, Fauzia Riaz

DOI: 10.35841/cancer-immunology.1.1.17-23

Abstract Full Text

Editorial P.24-25

Epigenetic altering drugs as immunotherapies.

Author(s): Rasika M. Samarasinghe

DOI: 10.35841/cancer-immunology.1.1.24-25

Abstract Full Text PDF

Review Article P.26-40

Modelling approaches in tumor microenvironment.

Author(s): Isaac Crespo, George Coukos, Marie-Agnes Doucey and Ioannis Xenarios

DOI: 10.35841/cancer-immunology.1.1.26-40

Abstract Full Text PDF

Editorial P.41-42

Immunotherapy in breast cancer: where we stand?

Author(s): Rosalin Mishra

DOI: 10.35841/cancer-immunology.1.1.41-42

Full Text PDF